BENJAMIN COLVIN: Open Payments
NPI 1730425281 · MONTGOMERY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$356 in 15 payments from 5 companies in 2025. Trend: 2023 $162 · 2024 $65 · 2025 $356
Food & beverage: $356
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $148 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Axsome Therapeutics, Inc. | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| ABBVIE INC. | 2 | $37 |
Products named: MOUNJARO, FARXIGA, Auvelity, CAPLYTA, UBRELVY, JARDIANCE, VRAYLAR.
Industry payments across LA — which companies pay providers there.
